140 related articles for article (PubMed ID: 1819740)
1. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
Sagach VF; Dmitrieva AV; Braquet P
Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
[TBL] [Abstract][Full Text] [Related]
2. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
Sagach VF; Dmitrieva AV
Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032
[TBL] [Abstract][Full Text] [Related]
3. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Filep JG; Braquet P; Mózes T
Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
Mózes T; Braquet P; Filep J
Am J Physiol; 1989 Oct; 257(4 Pt 2):R872-7. PubMed ID: 2802004
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.
Filep J; Hermán F; Braquet P; Mózes T
Biochem Biophys Res Commun; 1989 Jan; 158(2):353-9. PubMed ID: 2916986
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S
Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent effects of platelet-activating factor in the coronary circulation.
Sagach VF; Zhukova AV; Braquet P
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S85-9. PubMed ID: 1282996
[TBL] [Abstract][Full Text] [Related]
8. [Cardio- and hemodynamics of dogs during the development of postischemic shock reaction].
Sagach VF; Dmitrieva AV
Fiziol Zh (1978); 1989; 35(4):9-15. PubMed ID: 2792447
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
10. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
11. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia.
Minor T; Isselhard W; Yamaguchi T
J Surg Res; 1995 May; 58(5):536-40. PubMed ID: 7745967
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
Maruyama M; Farber NE; Vercellotti GM; Jacob HS; Gross GJ
Am Heart J; 1990 Sep; 120(3):510-20. PubMed ID: 2389687
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs.
Qian C; Guo ZM; Peters CJ; Liu CT
J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003
[TBL] [Abstract][Full Text] [Related]
14. The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion.
Wainwright CL; Parratt JR; Bigaud M
Eur Heart J; 1989 Mar; 10(3):235-43. PubMed ID: 2468494
[TBL] [Abstract][Full Text] [Related]
15. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
Sirén AL; Feuerstein G
Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
[TBL] [Abstract][Full Text] [Related]
16. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart.
Viossat I; Chapelat M; Chabrier PE; Braquet P
Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
19. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
Hu W; Kinnaird AA; Man RY
Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
